Case report: A rare low-grade fumarate hydratase-deficient renal cell carcinoma

被引:0
|
作者
Sun, Di [1 ]
Hu, Baohong [2 ]
Li, Xinna [1 ]
Yang, Ping [1 ]
Yu, Guohua [1 ]
机构
[1] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Pathol, Yantai, Peoples R China
[2] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Oncol, Yantai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
renal cell carcinoma; FH-deficient; low grade; case report; literature review;
D O I
10.3389/fonc.2024.1440119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim To study and analyze the clinicopathological features of low-grade fumarate hydratase-deficient renal cell carcinoma in order to improve the understanding of the diagnosis and management of rare and specific morphological cases of this tumor.Methods A case of low-grade FH-deficient renal cell carcinoma in a male is reported, and its clinicopathological features were analyzed and literature review was performed.Results A 48-year-old middle-aged male with no relevant positive clinical signs was admitted to the hospital with an incidental finding of a mass in the lower pole of the left kidney during abdominal CT examination. Pathomorphology showed that the tumor cells were arranged in a variety of structures and the cells were low grade eosinophilic. Immunohistochemistry showed Pax-8 (+), Vim (partially +), FH (-), CK7 (-), CD117 (-), P504s (partially +), CD10 (partially +), CA-9 (-), TFE3 (partially +), SDHB (+), CK20 (-), and Ki-67 (+, about 2%). Final pathologic diagnosis: FH-deficient renal cell carcinoma (low grade).Conclusion Single pure low-grade FH-deficient renal cell carcinoma of the kidney is extremely rare, and the image structure of this tumor exhibits diverse manifestations, which needs to be differentiated from many renal tumors in clinicopathological diagnosis in order to prevent misdiagnosis.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Fumarate hydratase-deficient renal cell carcinoma: an oncology care institutional experience
    Kamboj, Meenakshi
    Gupta, Gurudutt
    Pasricha, Sunil
    Mehta, Anurag
    Rawal, Sudhir
    Singh, Amitabh
    Sharma, Anila
    Durga, Garima
    Bansal, Divya
    Diwan, Himanshi
    APMIS, 2024, 132 (08) : 544 - 552
  • [22] Response to the Letter to the Editor Entitled "Do We Have Sufficient Evidence to Define Prognosis for 'Low-grade' Fumarate Hydratase-deficient Renal Cell Carcinoma?"
    Smith, Steven C.
    Hamza, Ameer
    Sirohi, Deepika
    Amin, Mahul B.
    ADVANCES IN ANATOMIC PATHOLOGY, 2022, 29 (03) : 181 - 182
  • [23] Pitfalls in Urine Cytology: A Case of Fumarate Hydratase-Deficient Renal Cell Carcinoma Initially Diagnosed as High-Grade Urothelial Carcinoma
    Cheng, Kai
    Zhang, Xuelian
    Zhou, Xiaodie
    Wang, Xiaotong
    Bao, Wei
    Rao, Qiu
    DIAGNOSTIC CYTOPATHOLOGY, 2025, 53 (01) : E11 - E16
  • [24] Hereditary leiomyomatosis and renal cell carcinoma/fumarate hydratase-deficient renal cell carcinoma: two primaries in one
    Storey, Benjamin
    Shugg, Nathan
    Grant, Alexander
    ANZ JOURNAL OF SURGERY, 2020, 90 (04) : E93 - E94
  • [25] Development of a Diagnostic Deep Learning Model for Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Lee, Yong Il
    Park, Changhyun
    Kang, Jiseon
    Park, Ja-Min
    Yoon, Sun Young
    Jeong, Jinahn
    Ahn, Bokyung
    Cho, Yong Mee
    Kim, Namkug
    LABORATORY INVESTIGATION, 2024, 104 (03) : S989 - S991
  • [26] Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Gleeson, Jack P.
    Nikolovski, Ines
    Dinatale, Renzo
    Zucker, Mark
    Knezevic, Andrea
    Patil, Sujata
    Ged, Yasser
    Kotecha, Ritesh R.
    Shapnik, Natalie
    Murray, Samuel
    Russo, Paul
    Coleman, Jonathan
    Lee, Chung Han
    Stadler, Zsofia K.
    Hakimi, A. Ari
    Feldman, Darren R.
    Motzer, Robert J.
    Reznik, Ed
    Voss, Martin H.
    Chen, Ying-Bei
    Carlo, Maria, I
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2910 - 2919
  • [27] Fumarate Hydratase-Deficient Renal Cell Carcinoma With Predominant Tubulocystic Features Mimics Tubulocystic Renal Cell Carcinoma
    Yang, Xiaoqun
    Liu, Yang
    Wang, Huafeng
    Xu, Yunze
    Zhang, Huizhi
    Zhao, Ming
    Luo, Xiaoqing
    Jin, Hongtao
    Xiong, Ji
    Tao, Lili
    Xu, Jiankun
    Zhou, Luting
    Li, Xiangyun
    Xu, Haimin
    Dong, Lei
    Wang, Chaofu
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (12) : 1358 - 1364
  • [28] A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients
    Lau, Hubert D.
    Chan, Emily
    Fan, Alice C.
    Kunder, Christian A.
    Williamson, Sean R.
    Zhou, Ming
    Idrees, Muhammad T.
    Maclean, Fiona M.
    Gill, Anthony J.
    Kao, Chia-Sui
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (01) : 98 - 110
  • [29] Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma
    Trpkov, Kiril
    Siadat, Farshid
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [30] Fumarate hydratase-deficient renal cell carcinoma presenting as pelvicalyceal filling defect: an unusual presentation of a rare disease
    Ajjikuttira, Aiyapa
    Sharma, Pranav
    Joshi, Andre
    Rhee, Handoo
    BMJ CASE REPORTS, 2021, 14 (03)